...
首页> 外文期刊>Journal of Neurochemistry: Offical Journal of the International Society for Neurochemistry >Identification of poly-ADP-ribosylated mitochondrial proteins after traumatic brain injury.
【24h】

Identification of poly-ADP-ribosylated mitochondrial proteins after traumatic brain injury.

机译:脑外伤后多ADP核糖基化线粒体蛋白的鉴定。

获取原文
获取原文并翻译 | 示例

摘要

Poly-ADP-ribosylation is a post-translational modification performed by poly(ADP-ribose) polymerases (PARP), involved in many diverse cellular functions including DNA repair, transcription, and long-term potentiation. Paradoxically, PARP over-activation under pathologic conditions including traumatic brain injury (TBI) results in cell death. We previously demonstrated that intra-mitochondrial poly-ADP-ribosylation occurs following excitotoxic and oxidative injury in vitro. Here we sought to identify mitochondrial proteins modified by poly-ADP-ribosylation after TBI in vivo. Poly-ADP-ribosylation within mitochondria from injured brain after experimental TBI in rats was first verified using western blot and immuno-electron microscopy. Poly-ADP-ribosylated mitochondrial proteins identified using a targeted proteomic approach included voltage-dependent anion channel-1, mitofilin, mitochondrial stress proteins, and the electron transport chain components F1F0 ATPase, cytochrome c oxidase, and cytochrome c reductase. To examine the functional consequences of mitochondrial poly-ADP-ribosylation, isolated rat brain mitochondria were exposed to conditions of nitrosative stress known to activate PARP. PARP activation-induced reductions in State 3 respiration were prevented by the PARP-1 inhibitor 5-iodo-6-amino-1,2-benzopyrone or exogenous poly(ADP-ribose) glycohydrolase. As the effects of PARP activation on mitochondrial respiration appear regulated by poly(ADP-ribose) glycohydrolase, a direct effect of poly-ADP-ribosylation on electron transport chain function is suggested. These findings may be of relevance to TBI and other diseases where mitochondrial dysfunction occurs.
机译:聚-ADP-核糖基化是由聚(ADP-核糖)聚合酶(PARP)进行的翻译后修饰,涉及许多不同的细胞功能,包括DNA修复,转录和长期增强。矛盾的是,在包括创伤性脑损伤(TBI)在内的病理条件下,PARP过度激活会导致细胞死亡。我们先前证明线粒体内多ADP-核糖基化发生在体外兴奋性毒性和氧化损伤后。在这里,我们试图鉴定在体内TBI后通过聚ADP-核糖基化修饰的线粒体蛋白。在大鼠的实验性TBI后,来自受伤脑线粒体内的聚ADP-核糖基化首先使用Western印迹和免疫电子显微镜验证。使用靶向蛋白质组学方法鉴定的聚ADP核糖基化线粒体蛋白包括电压依赖性阴离子通道1,线粒体蛋白,线粒体应激蛋白以及电子传输链组分F1F0 ATPase,细胞色素c氧化酶和细胞色素c还原酶。为了检查线粒体聚ADP-核糖基化的功能后果,将分离的大鼠脑线粒体暴露于已知可激活PARP的亚硝化应激条件下。 PARP-1抑制剂5-碘-6-氨基-1,2-苯并吡喃酮或外源性聚(ADP-核糖)糖水解酶可防止PARP活化引起的3状态呼吸减少。由于PARP激活对线粒体呼吸的影响似乎受聚(ADP-核糖)糖水解酶的调节,建议聚ADP-核糖基化对电子转运链功能的直接影响。这些发现可能与TBI和其他发生线粒体功能障碍的疾病有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号